Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus.
Wang XY, Martiniello-Wilks R, Shaw JM, Ho T, Coulston N, Cooke-Yarborough C, Molloy PL, Cameron F, Moghaddam M, Lockett TJ, Webster LK, Smith IK, Both GW, Russell PJ.
Wang XY, et al. Among authors: both gw.
Gene Ther. 2004 Nov;11(21):1559-67. doi: 10.1038/sj.gt.3302308.
Gene Ther. 2004.
PMID: 15343359